Literature DB >> 11965042

Incidence of donor renal fibromuscular dysplasia: does it justify routine angiography?

Kenneth A Andreoni1, Susan M Weeks, David A Gerber, Jeffery H Fair, Matthew A Mauro, Lynn McCoy, Lisa Scott, Mark W Johnson.   

Abstract

BACKGROUND: The use of digital subtraction angiography (DSA) versus helical CT angiography (CTA) or MR angiography (MRA) for live renal donor evaluation is still controversial. Although CTA and MRA can detect some proximal moderate to severe arterial changes caused by fibromuscular dysplasia (FMD), mild and distal moderate FMD are not detected well without angiography.
METHODS: This is a retrospective chart review of all potential, normotensive live renal donors at our center from July 1995 to June 2001. One hundred fifty-nine patients completed the donor evaluation process and underwent DSA.
RESULTS: Seven cases of FMD, an incidence of 4.4%, were discovered. These patients were eliminated from donation. The distribution of renal vessels for our 159 patients was single arteries bilaterally, 64.8%; single left with multiple right, 16.4%; double left with single right, 9.4%; and multiple bilateral arteries, 9.4%. Three of the seven FMD patients had bilateral disease. Two of the seven (28.6%) FMD patients have subsequently required antihypertensive medications, with one requiring angioplasty of a progressive FMD stenotic lesion.
CONCLUSIONS: We are concerned that CTA or MRA may overlook mild cases of DSA-detectable FMD. All seven FMD patients had single left renal arteries and would have undergone left donor nephrectomy. This would have resulted in their remaining right native kidneys having mild to moderate FMD in six of seven patients and in four donor kidneys having mild to moderate FMD. The need for antihypertensive medications in two of these seven potential donors within 4 years of their evaluation supports previous literature reports.

Entities:  

Mesh:

Year:  2002        PMID: 11965042     DOI: 10.1097/00007890-200204150-00018

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

1.  Fibromuscular dysplasia presenting as a renal infarction: a case report.

Authors:  Annelies Van den Driessche; Erik Van Hul; Malika Ichiche; Gert A Verpooten; Jean-Louis Bosmans
Journal:  J Med Case Rep       Date:  2010-06-30

Review 2.  Non-Atherosclerotic Vascular Disease in Women.

Authors:  Lee Joseph; Esther S H Kim
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-14

3.  Fibromuscular Dysplasia.

Authors:  David P Slovut; Jeffrey W Olin
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-06

4.  Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults.

Authors:  Elizabeth C Lorenz; Terri J Vrtiska; John C Lieske; John J Dillon; Mark D Stegall; Xujian Li; Eric J Bergstralh; Andrew D Rule
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

5.  Renal artery fibromuscular dysplasia in 2,640 renal donor subjects: a CT angiography analysis.

Authors:  Gavin A McKenzie; Gustavo S Oderich; Akira Kawashima; Sanjay Misra
Journal:  J Vasc Interv Radiol       Date:  2013-08-02       Impact factor: 3.464

Review 6.  Optimal management of renal artery fibromuscular dysplasia.

Authors:  Anders Gottsäter; Bengt Lindblad
Journal:  Ther Clin Risk Manag       Date:  2014-07-28       Impact factor: 2.423

Review 7.  Fibromuscular dysplasia.

Authors:  Pierre-François Plouin; Jérôme Perdu; Agnès La Batide-Alanore; Pierre Boutouyrie; Anne-Paule Gimenez-Roqueplo; Xavier Jeunemaitre
Journal:  Orphanet J Rare Dis       Date:  2007-06-07       Impact factor: 4.123

8.  Kidney transplantation from living donor with monolateral renal artery fibromuscular dysplasia using a cryopreserved iliac graft for arterial reconstruction: a case report and review of the literature.

Authors:  Rostand Emmanuel Nguefouet Momo; Paola Donato; Gabriele Ugolini; Francesco Nacchia; Luca Mezzetto; Gian Franco Veraldi; Stefano Marletta; Enrico Cavallo; Albino Eccher; Annamaria Giambanco; Daniela Cenzi; Luigino Boschiero
Journal:  BMC Nephrol       Date:  2020-10-28       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.